223 related articles for article (PubMed ID: 25826687)
21. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
Al-Dhfyan A; Alhoshani A; Korashy HM
Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
[TBL] [Abstract][Full Text] [Related]
22. Disruption of period gene expression alters the inductive effects of dioxin on the AhR signaling pathway in the mouse liver.
Qu X; Metz RP; Porter WW; Cassone VM; Earnest DJ
Toxicol Appl Pharmacol; 2009 Feb; 234(3):370-7. PubMed ID: 19038280
[TBL] [Abstract][Full Text] [Related]
23. Cobaltous chloride and hypoxia inhibit aryl hydrocarbon receptor-mediated responses in breast cancer cells.
Khan S; Liu S; Stoner M; Safe S
Toxicol Appl Pharmacol; 2007 Aug; 223(1):28-38. PubMed ID: 17599377
[TBL] [Abstract][Full Text] [Related]
24. Increased arylhydrocarbon receptor expression offers a potential therapeutic target for pancreatic cancer.
Koliopanos A; Kleeff J; Xiao Y; Safe S; Zimmermann A; Büchler MW; Friess H
Oncogene; 2002 Sep; 21(39):6059-70. PubMed ID: 12203118
[TBL] [Abstract][Full Text] [Related]
25. Estrogen and aryl hydrocarbon receptor expression and crosstalk in human Ishikawa endometrial cancer cells.
Wormke M; Castro-Rivera E; Chen I; Safe S
J Steroid Biochem Mol Biol; 2000 Apr; 72(5):197-207. PubMed ID: 10822009
[TBL] [Abstract][Full Text] [Related]
26. Signal transduction-mediated CYP1A1 induction by omeprazole in human HepG2 cells.
Kikuchi H; Hossain A
Exp Toxicol Pathol; 1999 Jul; 51(4-5):342-6. PubMed ID: 10445394
[TBL] [Abstract][Full Text] [Related]
27. Expression of functional aromatic hydrocarbon receptor and aromatic hydrocarbon nuclear translocator proteins in murine bone marrow stromal cells.
Lavin AL; Hahn DJ; Gasiewicz TA
Arch Biochem Biophys; 1998 Apr; 352(1):9-18. PubMed ID: 9521805
[TBL] [Abstract][Full Text] [Related]
28. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces plasminogen activator inhibitor-1 through an aryl hydrocarbon receptor-mediated pathway in mouse hepatoma cell lines.
Son DS; Rozman KK
Arch Toxicol; 2002 Jul; 76(7):404-13. PubMed ID: 12111005
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of the MEK-1/p42 MAP kinase reduces aryl hydrocarbon receptor-DNA interactions.
Yim S; Oh M; Choi SM; Park H
Biochem Biophys Res Commun; 2004 Sep; 322(1):9-16. PubMed ID: 15313166
[TBL] [Abstract][Full Text] [Related]
30. 2,3,7,8-Tetrachlorodibenzo-p-dioxin activation of the aryl hydrocarbon receptor/aryl hydrocarbon receptor nuclear translocator pathway causes developmental toxicity through a CYP1A-independent mechanism in zebrafish.
Carney SA; Peterson RE; Heideman W
Mol Pharmacol; 2004 Sep; 66(3):512-21. PubMed ID: 15322242
[TBL] [Abstract][Full Text] [Related]
31. Aryl hydrocarbon receptor expression and activity in cerebellar granule neuroblasts: implications for development and dioxin neurotoxicity.
Williamson MA; Gasiewicz TA; Opanashuk LA
Toxicol Sci; 2005 Feb; 83(2):340-8. PubMed ID: 15537747
[TBL] [Abstract][Full Text] [Related]
32. Analysis of aryl hydrocarbon receptor-mediated signaling during physiological hypoxia reveals lack of competition for the aryl hydrocarbon nuclear translocator transcription factor.
Pollenz RS; Davarinos NA; Shearer TP
Mol Pharmacol; 1999 Dec; 56(6):1127-37. PubMed ID: 10570039
[TBL] [Abstract][Full Text] [Related]
33. Activation of the aryl hydrocarbon receptor pathway enhances cancer cell invasion by upregulating the MMP expression and is associated with poor prognosis in upper urinary tract urothelial cancer.
Ishida M; Mikami S; Kikuchi E; Kosaka T; Miyajima A; Nakagawa K; Mukai M; Okada Y; Oya M
Carcinogenesis; 2010 Feb; 31(2):287-95. PubMed ID: 19755661
[TBL] [Abstract][Full Text] [Related]
34. Aryl hydrocarbon receptor activation of an antitumor aminoflavone: basis of selective toxicity for MCF-7 breast tumor cells.
Loaiza-Pérez AI; Kenney S; Boswell J; Hollingshead M; Alley MC; Hose C; Ciolino HP; Yeh GC; Trepel JB; Vistica DT; Sausville EA
Mol Cancer Ther; 2004 Jun; 3(6):715-25. PubMed ID: 15210858
[TBL] [Abstract][Full Text] [Related]
35. p-Anilinoaniline enhancement of dioxin-induced CYP1A1 transcription and aryl hydrocarbon receptor occupancy of CYP1A1 promoter: role of the cell cycle.
Elliott A; Joiakim A; Mathieu PA; Duniec-Dmuchowski Z; Kocarek TA; Reiners JJ
Drug Metab Dispos; 2012 May; 40(5):1032-40. PubMed ID: 22344700
[TBL] [Abstract][Full Text] [Related]
36. Functional involvement of the Brahma/SWI2-related gene 1 protein in cytochrome P4501A1 transcription mediated by the aryl hydrocarbon receptor complex.
Wang S; Hankinson O
J Biol Chem; 2002 Apr; 277(14):11821-7. PubMed ID: 11805098
[TBL] [Abstract][Full Text] [Related]
37. Distinct roles for aryl hydrocarbon receptor nuclear translocator and ah receptor in estrogen-mediated signaling in human cancer cell lines.
Labrecque MP; Takhar MK; Hollingshead BD; Prefontaine GG; Perdew GH; Beischlag TV
PLoS One; 2012; 7(1):e29545. PubMed ID: 22235307
[TBL] [Abstract][Full Text] [Related]
38. Involvement of a post-transcriptional mechanism in the inhibition of CYP1A1 expression by resveratrol in breast cancer cells.
Lee JE; Safe S
Biochem Pharmacol; 2001 Oct; 62(8):1113-24. PubMed ID: 11597580
[TBL] [Abstract][Full Text] [Related]
39. Nuclear uptake of the Ah (dioxin) receptor in response to omeprazole: transcriptional activation of the human CYP1A1 gene.
Quattrochi LC; Tukey RH
Mol Pharmacol; 1993 Apr; 43(4):504-8. PubMed ID: 8386305
[TBL] [Abstract][Full Text] [Related]
40. Aryl hydrocarbon receptor (AHR) and AHR nuclear translocator (ARNT) expression in Baikal seal (Pusa sibirica) and association with 2,3,7,8-TCDD toxic equivalents and CYP1 expression levels.
Kim EY; Iwata H; Suda T; Tanabe S; Amano M; Miyazaki N; Petrov EA
Comp Biochem Physiol C Toxicol Pharmacol; 2005 Jul; 141(3):281-91. PubMed ID: 16111922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
